Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

The Medicines Company Said to Weigh Strategic Options for European Unit

Medicines Co. is weighing options including a sale for its European business as the drug developer seeks to benefit from the boom in health-care deals, according to people familiar with the matter. The company is working with financial advisers from Rothschild on the review, which may lead to a sale, licensing agreement or partnership for […]

Read More »

Montefiore Statement On The Supreme Court Upholding Key Provision Of The Affordable Care Act

NEW YORK, June 25, 2015 /PRNewswire-USNewswire/ — Earlier today, the Supreme Court ruled 6-3 that the Affordable Care Act will remain unchanged, and that the government can continue to subsidize health care coverage through the federal exchange in states without state exchanges. The overwhelming decision by the Supreme Court will save lives by continuing to […]

Read More »

Rx Outreach: King vs. Burwell Still Leaves Millions Struggling To Find Affordable Medication

ST. LOUIS, June 25, 2015 /PRNewswire/ — Despite the ruling by the Supreme Court in the King vs. Burwell case to uphold a key regulation supporting the Affordable Care Act allowing subsidies for state-run and federal exchanges, it remains that in this great nation, affordable healthcare for individuals and families is not something that can be […]

Read More »

In A Textbook Application Of Statutory Construction, The Supreme Court Saves Obamacare

Almost three years ago to the day, the Supreme Court shielded the Affordable Care Act (ACA) from a constitutional assault that nearly decapitated President Barack Obama’s signature legislative achievement. In a ruling issued this morning, the Court also saved the insurance subsidies that serve as a key provision of the Act, bringing to an end […]

Read More »

The US Oncology Network Applauds Introduction of Medicare Patient Access to Treatment Act

WASHINGTON, June 25, 2015 /PRNewswire-USNewswire/ — The US Oncology Network – one of the nation’s largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care – today commended Representatives Mike Pompeo (R-KS) and Don Beyer (D-VA) for introducing the Medicare Patient Access to Treatment Act (H.R. 2895), legislation to level the […]

Read More »

MM-398 Receiving the Priority Review Designation by US FDA for New Drug Application and the Acceptance of Market Authorization Application by EMA in Post-Gemcitabine Metastatic Pancreatic Cancer

TAIPEI, June 25, 2015 /PRNewswire/ — PharmaEngine, Inc. (TWO: 4162) announced that (1) its license partner, Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK), has received the notification from the US Food and Drug Administration (FDA) for the acceptance and the grant of the priority review designation for their New Drug Application (NDA); and (2) its sublicense partner, […]

Read More »

Supreme Court Keeps ObamaCare on Life Support at Taxpayer Expense, by Rewriting Statute, States Association of American Physicians and Surgeons

TUCSON, Ariz., June 25, 2015 /PRNewswire-USNewswire/ — In a 6-to-3 decision in King v. Burwell, the U.S. Supreme Court upheld the IRS rule permitting Affordable Care Act (ACA or ObamaCare) subsidies to flow through federal Exchanges, in clear contradiction to the wording of the statute, states the Association of American Physicians and Surgeons. As noted […]

Read More »

Alcon launches new hydrogen peroxide-based contact lens cleaning disinfecting solution in the US

FORT WORTH, Texas, June 25, 2015 /PRNewswire/ — Alcon, the global eye care leader and a division of Novartis, announced today the US launch of CLEAR CARE® PLUS Cleaning & Disinfecting Solution containing HydraGlyde® Moisture Matrix technology, for cleaning and disinfecting contact lenses. Preservative-free hydrogen peroxide-based solutions effectively clean and disinfect contact lenses, resulting in […]

Read More »

New Clinical Study of Flublok Influenza Vaccine Shows That Groundbreaking Flublok Is More Effective Than the Traditional Flu Shot

MERIDEN, Conn., June 25, 2015 /PRNewswire/ — Protein Sciences Corporation announced today topline data showing that Flublok® Quadrivalent – the quadrivalent version of FDA-approved trivalent Flublok® influenza vaccine – outperformed a traditional influenza vaccine last season and was better at preventing the flu.   The company presented the results of a clinical trial comparing Flublok Quadrivalent to […]

Read More »

The Good News About Our Battle With Global Heath Threats From MERS, SARS, Ebola And The Flu

In recent weeks, the threat to South Korea from Middle East Respiratory Syndrome, better known as MERS, has exploded. Over the last 18 months or so, Ebola has hit West Africa hard and penetrated the borders of the United States and Europe. During the previous decade, H1N1 Flu and Severe Acute Respiratory Syndrome (SARS) infected […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom